Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
TapImmune Inc. New Add to My Watchlist (OTCBB: TPIV) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     TapImmune Inc. 0.49 -0.05 (-9.26%) 262,131
3590 West 41st Avenue
Unit 2
Vancouver, B.C., V6N 3E6 CN
(604) 264-8274
fax
www.tapimmune.com
CEO Dr. Glynn Wilson, Ph.D.
Auditor Dale Matheson Carr-Hilton Labunte LLP
Exchange Traded OB
ISIN Number US8760332002
CIK Number 1094038
NAICS Code 325414
Business Summary
The Company focused on developing therapeutics to treat serious disorders, for cancer and infectious diseases.
Number of Employees 1
Share Fundamentals
Market Cap 18.02M
Shares Outstanding 36.78M
Float N/A
Short Interest N/A
Financial Strength
Revenue (TTM) N/A
Earnings (TTM) -$1,618,902
Quick Ratio 0.1:1
Current Ratio 0.2:1
Total Debt/Equity 0:1
Profitability
Gross Margin N/A
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Investing News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs